Cytopathology

News

Diagnosing brain cancer

A blood test which could help to accelerate the diagnosis of brain cancer has been developed.

Cytopathology

News

November news in numbers

A breakdown of science news this month, in numbers.

Cytopathology

News

New cancer-driving mutation

Scientists have discovered a novel cancer-driving mutation in the vast non-coding regions of the human cancer genome, also known as the “dark matter” of human cancer DNA.

Cytopathology

News

NHS screening GPs giving alcohol advice – linked to pay

In 2008 the Department of Health in England introduced financial incentives to encourage GPs to talk to patients about their drinking. There was a small, gradual increase in screening and the provision of alcohol advice.

Cytopathology

News

Australia top for cancer survival

A global study has found that Australia’s high cancer survival rates are attributed to early detection.

Cytopathology

News

Blood test aids lung cancer detection

A trial in Scotland has shown that using a blood test to detect lung cancer earlier can significantly reduce late-stage presentation of the disease.

Cytopathology

Science

October journal-based learning exercises

Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

Cytopathology

News

Predicting lung cancer

Frank Sullivan, a Director of Research at the University of St Andrews, outlines a new blood test that could lead to earlier lung cancer diagnosis.

Cytopathology

News

Ebola breakthrough

Ebola could soon be “preventable and treatable”, after a trial of two drugs showed significantly improved survival rates.

Cytopathology

News

Targeting the spread of pancreatic cancer

An international team of scientists has revealed how aggressive pancreatic cancer cells change their environment to enable metastasis – the main cause of pancreatic cancer-related death.

Cytopathology

News

Urine test for prostate cancer

Scientists have developed a urine test to diagnose aggressive prostate cancer and predict whether patients will require treatment up to five years earlier than standard clinical methods.

Cytopathology